I came to Selank after trying the usual anxiety stack (ashwagandha, L-theanine, magnesium) and walking away underwhelmed. The supplements helped a little but never addressed the actual problem: that low-level mental noise that makes focused work feel like pushing through mud.
Selank is a synthetic peptide that Russia registered in 2009 as nasal drops for anxiety states and neurasthenia. It is a drug there, not a supplement. It is not FDA approved, and in the US it is sold as a research compound.
I ran it as a nasal spray for 6 weeks. This guide covers what lab and animal studies show about how it works, the protocol I followed, what changed for me week by week, and where the evidence is thin.
What Selank Actually Is
Selank (TP-7) is a heptapeptide, seven amino acids long, with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences in Moscow, with the Zakusov Research Institute of Pharmacology. Russia registered it in 2009 as 0.15% nasal drops for anxiety states and neurasthenia, and the current Russian label lists it as sold without a prescription.
It is derived from tuftsin (Thr-Lys-Pro-Arg), a four-amino-acid fragment of the heavy chain of immunoglobulin G that stimulates phagocytic immune cells. Selank adds Pro-Gly-Pro to tuftsin's sequence; its developers say this was done to make the peptide more stable and longer acting.
PubMed lists 76 records on Selank (search of 27 October 2026), covering anxiety, memory, immune effects and gene activity. Five of them report giving it to people.
How Selank Might Work: Three Proposed Mechanisms
Lab and animal studies point to three possible mechanisms. Only the enkephalin finding has been checked in people, in blood samples from one trial; the GABA and BDNF findings come from rats, mice and cells.
1. GABA-A Modulation (Rat Brain Membranes)
Selank's developers propose this as one of its anti-anxiety mechanisms. In rat brain membranes, Selank changed how GABA bound to its receptors the way a positive allosteric modulator does. It also blocked the modulating effect of diazepam, and the authors concluded that its binding site is probably not the benzodiazepine site, though the two may partly overlap.
If this holds in people, Selank would strengthen the signal GABA already sends rather than switch the receptor on by itself, which is what a direct agonist such as phenibut does at GABA-B receptors. No study has tested this in people.
Why this distinction matters:
Direct agonists such as phenibut act on the receptor themselves; phenibut works at GABA-B receptors and on a calcium-channel subunit. Users commonly report tolerance. Withdrawal can be severe: in a review of 25 published phenibut withdrawal cases, 11 people (44%) were admitted to intensive care.
Positive allosteric modulators, such as benzodiazepines, strengthen GABA's effect but do not open the receptor alone. That does not rule out dependence: since 2020 the FDA has required a boxed warning on abuse, dependence and withdrawal for every benzodiazepine. Selank behaved like a modulator in rat brain membranes. No study in people has tested it for tolerance or dependence; in rats given it daily for 4 weeks, its anti-anxiety effect held.
One rat study offers a possible clue about sedation. After a single nasal dose, activity of the gene for orexin, a wakefulness signal, fell about 25-fold in the frontal cortex at 1 hour and rose about 128-fold at 3 hours; the tissue was pooled from 5 rats per time point. The authors suggested this shift toward wakefulness might explain why Selank lacks the sedating effect of benzodiazepines. No study has tested that idea in people.
Published evidence:
- In rat brain membranes, Selank changed GABA binding the way a positive allosteric modulator does
- In rats, one nasal dose changed the activity of 29 of 77 neurotransmission genes in the frontal cortex at 1 hour and 17 at 3 hours, among them GABA-A receptor subunit genes; the often-quoted 45 genes counts Selank and GABA together
- In human neuroblastoma cells (IMR-32), Selank alone changed none of the genes studied; added with GABA, it cut the number of genes GABA changed from 14 to 1
2. Enkephalinase Inhibition (Blood Samples and Mice)
Enkephalins are opioid peptides the body makes itself, and enzymes called enkephalinases break them down. In human blood samples in a test tube, Selank slowed these enzymes. In mice, a dose of Selank lengthened the half-life of leu-enkephalin in blood in the more anxious BALB/c strain but not in C57BL/6 mice.
Two Russian studies found a shortened enkephalin half-life in the blood of people with generalized anxiety. In a trial of 62 patients with generalized anxiety or neurasthenia, this half-life rose in the 30 given Selank, mostly in those with generalized anxiety.
Published evidence:
- In human serum in a test tube, Selank blocked enkephalin-degrading enzymes with an IC50 of 20 micromolar
- In human plasma in a test tube, the IC50 was 15 micromolar; the same paper reports a shortened enkephalin half-life in the blood of people with generalized anxiety
- In a trial of 62 patients, the blood half-life of leu-enkephalin rose in the 30 given Selank
- In mice, Selank lengthened the blood half-life of leu-enkephalin in the BALB/c strain only
- In mice, the opioid blocker naloxone weakened Selank's anti-anxiety effect in one strain (BALB/c) and strengthened it in another (C57BL/6)
3. BDNF Changes (Rat Data)
Selank is often described online as a BDNF booster. PubMed has two rat studies that measured BDNF after Selank. In one, a nasal dose changed BDNF expression in the hippocampus; PubMed has no abstract for it, so the size and direction are not given there. In the other, rats that drank alcohol for 30 weeks had more BDNF in the hippocampus and frontal cortex, and 7 days of injected Selank prevented that rise and the memory problems seen during withdrawal.
Two rat studies are too few to say whether Selank raises BDNF or steadies it.
Published evidence:
- BDNF expression in the rat hippocampus after a nasal dose (Inozemtseva et al., 2008; no abstract in PubMed)
- Selank prevented the alcohol-induced BDNF rise and memory problems in rats given ethanol for 30 weeks (Kolik et al., 2019)
Why Nasal Spray and Not Injection
Convenience is one reason, and the registered Russian product is nasal drops. In mice, the route also changed the results.
A study in mice gave Selank (300 mcg/kg a day for 5 days) either into the nose or by injection into the abdomen. Both routes reduced anxiety-like behavior, but only in the more anxious BALB/c strain. Injected Selank raised GABA receptor binding sites in the frontal cortex by 38%; nasal Selank instead raised NMDA receptor binding sites by 23% and left GABA receptors unchanged. The authors suggested the two routes differ in how the peptide is absorbed and broken down.
Selank is a small peptide (751.9 daltons). The Russian label says it appears in blood 30 seconds after nasal use and reaches brain tissue, and that blood levels fall over 5 to 5.5 minutes; it gives an absolute nasal bioavailability of 92.8%. The label does not say whether these figures come from animals or people, and no pharmacokinetic study in people appears in PubMed. In rats, a tritium-labeled form was traced in brain tissue after nasal use.
Selank: Blood Level After a Nasal Dose (Illustration)
An illustration, not measured data. The Russian label says blood levels fall over 5 to 5.5 minutes (species not stated). How long one dose works has not been measured in people.
The 6-Week Protocol I Followed
I used a pre-made nasal spray format at 50mcg per spray. Pre-dosed nasal sprays eliminate the reconstitution step and the dosing guesswork that comes with DIY vial-based setups.
6-Week Dosing Protocol I Followed
| Week | Per Session | Sessions/Day | Daily Total | Notes |
|---|---|---|---|---|
| 1 | 50mcg (1 spray/nostril) | 2x (AM + early PM) | ~200mcg | Starting low to assess tolerance |
| 2-4 | 100mcg (2 sprays/nostril) | 2x (AM + early PM) | ~400mcg | Moved to standard range |
| 5-6 | 100mcg (2 sprays/nostril) | 2x (AM + early PM) | ~400mcg | Held steady, no need to increase |
How this compares: The Russian label gives 2 drops of the 0.15% solution in each nostril 3 times a day for 14 days, repeatable after 1 to 3 weeks, and does not state a microgram dose. The trial abstracts in PubMed do not give doses. This protocol uses 2 doses a day for 6 weeks.
Timing: First session 20-30 minutes after waking. Second session early afternoon, no later than 3pm. The cutoff is a precaution based on the rat orexin gene finding above; no study in people has tested whether Selank delays sleep.
Administration: Head tilted slightly forward. Spray into each nostril. Gentle sniff. Don't inhale hard or you'll send it past the olfactory mucosa into your throat. Hold position for 10-15 seconds.
What I Actually Noticed: Week by Week
This is one person's experience, with no placebo and no blinding. Read it as a report, not as evidence.
Week 1
My first impression was "is this doing anything?" No dramatic shift. By day 4-5 I realized the constant background hum of low-grade anxiety had dialed down. Not gone. Just quieter. Like someone turned the volume from 6 to 3. No sedation, no brain fog, no emotional blunting. I was still me, just less noisy internally.
Week 2
The anxiety reduction became more consistent. What surprised me was focus. Not stimulant focus where you lock onto one thing. More like the mental friction before starting tasks reduced. I'd sit down to work and actually start instead of checking my phone for 20 minutes first. This felt like a downstream effect of reduced anxiety rather than a direct cognitive boost.
Weeks 3-4
My peak effect window. The quietness became my new baseline. I started noticing it most when doing things that normally spike my anxiety: difficult conversations, high-pressure deadlines, crowded environments. My response to those situations felt more measured. Less reactive. I could think through things instead of reacting to them.
Weeks 5-6
Diminishing novelty but consistent effect. I noticed no tolerance: same dose, same result. Sleep improved noticeably. Not faster onset but better maintenance, staying asleep through the night. Got a cold during week 5 that cleared faster than my usual timeline. Could be coincidence; one cold in one person proves nothing.
After Stopping
Effects faded gradually over 3-4 days. No withdrawal. No rebound anxiety. No crash. Background noise crept back to baseline over the first week. One Russian trial of 60 patients, which compared Selank with phenazepam, reported something similar: Selank's anti-anxiety effect lasted a week after the last dose.
Selank vs. The Other Anxiety Options
This is where people usually ask "why not just take X instead?" Fair question. No study has compared Selank with phenibut, L-theanine or ashwagandha, so the notes below set separate studies side by side.
Selank vs. Phenibut
Different mechanism and risk profile. Phenibut acts directly on GABA-B receptors and on a calcium-channel subunit, and users commonly report tolerance. In published cases, withdrawal followed as little as one week of daily use, and 11 of 25 people with withdrawal needed intensive care. Selank changed GABA-A binding in rat brain membranes; no study in people has tested it for tolerance or dependence, and a 2024 review found no reported cases of Selank withdrawal. They are not interchangeable, even though both are Russian anxiety drugs.
Selank vs. L-Theanine
L-theanine is an amino acid from tea. It is cheap and well tolerated: a 2026 review of 31 placebo-controlled trials found no serious adverse events, a faster reaction time after one 200 mg dose, and inconsistent effects on anxiety. In a trial of 48 adults, 200 mg did not change caffeine's jitteriness.
Selank vs. Ashwagandha
In lab binding tests, an ashwagandha root extract bound GABA-A receptors. Its trials run for weeks: in 64 stressed adults, 300 mg twice a day for 60 days lowered stress scores and cortisol more than placebo.
Selank vs. Benzodiazepines
Benzodiazepines are GABA-A positive allosteric modulators. In rat brain membranes, Selank changed GABA binding in a similar way, at a site that appeared to differ from diazepam's. Benzodiazepines cause sedation, and since 2020 the FDA has required a boxed warning on abuse, dependence and withdrawal for all of them. In a Russian trial of 62 patients, the anxiety relief of the 30 given Selank was similar to that of the 32 given medazepam, with added anti-fatigue and stimulant effects, and in a trial of 70 patients, the 40 given Selank with phenazepam had fewer phenazepam side effects, including sedation and memory problems, than the 30 on phenazepam alone. Benzodiazepines have decades of trials behind them; Selank's treatment trials in PubMed enrolled 62, 60 and 70 patients, all in Russia.
| Selank | Phenibut | L-Theanine | Benzodiazepines | |
|---|---|---|---|---|
| Mechanism | GABA-A PAM (rat data) | GABA-B agonist | Tea amino acid | GABA-A PAM (BZD site) |
| Onset | Not measured in people | No onset study found | 30-60 min (attention tests) | Varies by drug |
| Sedation | Not a listed side effect | Yes | Not established | Yes |
| Tolerance | Not studied in people | Commonly reported | Not studied | Quick for sedation; unclear for anxiety |
| Dependence | Not studied in people | Reported in case reports | Not studied | Physical, after days to weeks |
| Withdrawal | None reported (2024 review) | Can require ICU | Not studied | Seizure risk |
| Rx Status | Russia: no Rx; US: not approved | Not a legal US supplement | Supplement | Prescription |
Adding Selank to an existing stack?
Check for interactions before you start. The BodyHackGuide Interaction Checker flags known interactions between the nootropics in its database, Selank included.
The Immune Angle
Selank is derived from tuftsin, a four-amino-acid fragment of immunoglobulin G that stimulates phagocytic immune cells, the cells that engulf microbes. No study in PubMed has tested whether Selank keeps that effect.
In a Russian study, Selank added to blood cells in a test tube switched off IL-6 gene activity in cells from patients with depression but not in cells from healthy people, while IL-6 protein in the same cultures rose. In patients with generalized anxiety or neurasthenia given Selank for 14 days, the balance of Th1 and Th2 cytokines in blood shifted. In rats under 20 days of social stress, injected Selank brought raised IL-1 beta and IL-6 back to near-normal levels.
In cell culture, Selank added a day before infection stopped an influenza A strain from multiplying; in mice it raised interferon-alpha gene activity, and survival was best when it was given before infection.
What You Need to Know About the Evidence
Here is what the published evidence covers and what it leaves out.
What exists: lab and animal data
Rat, mouse and cell studies, nearly all from Russian groups, describe changes in GABA binding, enkephalin breakdown, BDNF, cytokines and gene activity. Two were also measured in the blood of patients given Selank: enkephalin half-life (in a trial of 62 patients, 30 of them on Selank) and the cytokine balance (in patients treated for 14 days). The GABA, BDNF and gene findings have not been measured in people.
What's weak: The clinical evidence
PubMed has three treatment studies, of 62, 60 and 70 patients, all in Russia, each comparing Selank with a benzodiazepine or adding it to one; none had a placebo group. The only placebo-controlled study gave one dose of Selank, Semax or placebo to 52 healthy adults during brain scans. Every human study in PubMed lists Nikolay Myasoedov, of the institute where Selank was developed, as an author. No Selank study is registered on ClinicalTrials.gov, and no study in people from outside Russia appears in PubMed.
What's missing entirely:
- No study of use in people beyond a few weeks; the Russian label's course is 14 days
- No study of Selank with SSRIs, SNRIs or gabapentinoids
- No animal study of fertility or pregnancy and no cancer study in PubMed; one test-tube study in mouse embryonic stem cells reported no toxic effect, though Selank cut the share of cells that became GABA neurons by 61%. The Russian label rules out pregnancy because no clinical studies were done
- No lethal-dose (LD50) figure in PubMed
The Russian label lists only allergic reactions and an unpleasant taste as side effects. A 2024 review found no reported cases of Selank withdrawal or death, and a German poison center (GIZ-Nord in Goettingen) had received no inquiries about Selank, against 17 about phenibut from 2008 to 2022. A small evidence base with few reported problems is not the same as evidence of safety.
Quick Reference
Compound
Selank (TP-7)
Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro
Molecular weight
751.9 Da
Time in blood
Falls over 5-5.5 min (Russian label)
Duration of effect
Not measured in people
Intranasal bioavailability
92.8% (Russian label, species not stated)
Russian registration
2009, 0.15% nasal drops
FDA status
Not approved
Community protocol
200-400mcg IN, 2-3x daily
Contraindications
Pregnancy, lactation, <18 (Russian label)
Frequently Asked Questions
What is Selank?
Selank (TP-7) is a synthetic peptide of seven amino acids: tuftsin, a fragment of immunoglobulin G, with Pro-Gly-Pro added. Russia registered it in 2009 as 0.15% nasal drops for anxiety states and neurasthenia, and it is sold there without a prescription. It is not approved by the FDA. In rat brain membranes it changed GABA binding the way a positive allosteric modulator does; that has not been measured in people.
What is the correct Selank nasal spray dosage?
Community protocols use 200-400mcg per day total, split across 2-3 sessions. Beginners start at ~200mcg/day (50mcg per spray, 1 spray per nostril, 2x daily). This protocol's maintenance dose is 400mcg/day (100mcg per session, 2x daily). The Russian label instead gives 2 drops of the 0.15% solution in each nostril 3 times a day for 14 days and does not state a microgram dose. This protocol avoids doses after 3pm as a precaution: in rats, orexin gene activity in the frontal cortex rose about 128-fold 3 hours after a nasal dose, and no study in people has tested whether Selank delays sleep. Use the dosage calculator if you're working from a raw vial.
How long does it take for Selank to start working?
No study in people has timed the onset of Selank's anti-anxiety effect. In a brain-scan study of 52 healthy adults given one dose of Selank, Semax or placebo, scans 5 and 20 minutes later showed connectivity changes with the peptides. The Russian label's course lasts 14 days, and in one Russian trial of 60 patients that compared Selank with phenazepam, Selank's anti-anxiety effect lasted a week after the last dose. In my own 6-week run, background anxiety eased by day 4 or 5; that is one person's report, not a study.
Is Selank safe for long-term use?
No study in people has tested Selank for tolerance or dependence or followed use beyond a few weeks. The Russian label's course lasts 14 days and can be repeated after 1 to 3 weeks. A 2024 review found no reported cases of Selank withdrawal. No study has tested it with SSRIs, SNRIs or gabapentinoids, and PubMed has no animal study of fertility or pregnancy and no cancer study of it. Community practice is to cycle Selank (e.g., 4-6 weeks on, 2+ weeks off) rather than use it continuously. Check the interaction checker before stacking with other compounds.
Can you stack Selank with Semax?
Yes. Selank and Semax are often stacked, and their proposed mechanisms differ: Selank changed GABA binding in rat brain membranes, while Semax raised BDNF in the rat hippocampus and changed serotonin turnover in mice. A typical approach: Semax in the morning for focus and drive, Selank midday for anxiety. No study has given the two together, so introduce them separately: observe each for 5-7 days before combining. See the complete nootropic stack guide for broader stacking principles.
What is Selank's half-life and how does it affect dosing?
The Russian label says Selank appears in blood 30 seconds after nasal use and that blood levels fall over 5 to 5.5 minutes. It does not say whether these figures come from animals or people, and no human pharmacokinetic study appears in PubMed. No study has measured how long one dose works in people; in rats, gene activity in the frontal cortex was still changed 3 hours after a nasal dose. The label schedules 3 doses a day, and community protocols use 2 to 3. Use the half-life visualizer to model dosing windows.
Selank vs phenibut: what's the difference?
Phenibut acts directly on GABA-B receptors and on a calcium-channel subunit. Users commonly report tolerance, and withdrawal can be severe: in 25 published withdrawal cases, 11 people needed intensive care. Selank changed GABA-A binding in rat brain membranes; no study in people has tested it for tolerance or dependence, and a 2024 review found no reported withdrawal cases. They are not interchangeable, even though both are Russian anxiety drugs.
Where can you buy legitimate Selank nasal spray?
Selank is not FDA-approved. The FDA lists its nomination for use in compounding as withdrawn and notes a possible risk of immunogenicity and missing human safety data. In the US, research-chemical vendors sell it for research use only; in Russia it is sold as 0.15% nasal drops without a prescription. Always verify third-party testing and reconstitution quality. Avoid vendors who won't publish a certificate of analysis. See the nasal nootropics bioavailability ranking for quality-vetting criteria.
Studies Referenced
Related Guides
Related deep-dive comparison
Selank vs Semax
The Russian heptapeptide pair: anxiolytic vs cognitive, mechanism, stacking, N-acetyl variants
Founder of BodyHackGuide. Writes the site's guides on peptide research, nootropics and vendor quality, and posts as u/BioChonch on Reddit.
Get compound research breakdowns by email
Mechanisms, dosing research and vendor notes, on no set schedule. Unsubscribe anytime.
Was this page helpful?